Latest News- High Throughput Screening (HTS) Market: Target identification and validation is expected to lead the Application segment during 2024-2028

The High Throughput Screening (HTS) Market is being driven by Rise in R and D investments

The High Throughput Screening (HTS) Market is expected to grow at a CAGR of 12.12% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 19.9 billion. In the high throughput screening (HTS) market, the focus shifts from brand and product visibility towards enhancing distribution networks and ensuring product availability for niche end-users. Due to the technical nature of these products and the specific requirements of the industry, traditional advertising and marketing strategies hold limited value. Thermo Fisher Scientific acknowledges this challenge and offers additional resources to support customers, including detailed explanations of techniques through documents, brochures, and interactive videos on platforms like YouTube. By prioritizing customer support and education, key vendors aim to increase awareness and adoption of HTS solutions. 

Get more information on High Throughput Screening (HTS) Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Application
  • Target identification and validation
  • Primary screening
  • Secondary screening
  • Toxicology assessment
  • Stem cell research
• End-user
  • Pharmaceutical and biotechnology companies
  • Academic and research institutes
  • CROs
• Technology
  • Cell-based Assays
  • Lab-on-a-chip Technology (LOC)
  • Label-free Technology
  • Ultra High Throughput Screening
  • 3D Cell Cultures
  • High-Content Screening (HCS)
• Geography
  • North America
    • US
  • Europe
    • Germany
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rise in R and D investments
• Increasing prevalence of chronic diseases
• Patent expiration of drugs

However, the market also witnesses some limitations, which are as follows:

• Shortage of trained healthcare professionals
• High cost of drug discovery process and limitations of HTS
• Import duty and distribution issues in developing countries

Benefits of Buying Global High Throughput Screening (HTS) Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in High Throughput Screening (HTS) Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The High Throughput Screening (HTS) market encompasses technologies and solutions that enhance the capacity for identifying and optimizing potential drug candidates. Key components include throughput capacity expansion through assay miniaturization, automation software, data integration, and data visualization. Hit confirmation, lead optimization, and structure-activity relationships are critical downstream processes. Pharmacokinetic and pharmacodynamic profiling, preclinical studies, and clinical pharmacology are essential steps towards therapeutic areas, including disease pathways, drug resistance, drug delivery, and clinical trials design. Patient recruitment, clinical endpoints, data interpretation, regulatory requirements, and intellectual property are crucial aspects of bringing new drugs to market. Additionally, HTS plays a significant role in drug repurposing, target identification, and target discovery.

Market Research Overview

The High Throughput Screening (HTS) market is a significant segment of the global life sciences tools and services industry. This market encompasses companies specializing in compound libraries, screening assays, and technologies that facilitate drug discovery, lead identification, and hit identification. The parent market, the global life sciences tools and services sector, includes entities involved in the R&D of a range of product categories, such as capital equipment, instruments, accessories, and consumables, used for research and development in pharmaceuticals, biotechnology, and laboratory diagnosis. Additionally, it covers life sciences-related services, including contract research, contract manufacturing, and contract sales. The global life sciences tools and services market, valued at USD132.53 billion in 2023, is projected to expand moderately during the forecast period.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/